Company Filing History:
6 out of 46 
5 out of 5 
1 out of 1 Years Active: 2017-2025
Title: Stefanie Kluepfel-Stahl: Innovator in Toxin Neutralization
Introduction
Stefanie Kluepfel-Stahl is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of biochemistry, particularly in the development of isolated polypeptides that target toxins. With a total of six patents to her name, her work has the potential to impact medical treatments and safety.
Latest Patents
One of her latest patents focuses on isolated polypeptides of the toxin A and toxin B proteins. This invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides that comprise the receptor binding domains of toxin A and toxin B, as detailed in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. These isolated polypeptides may be utilized to neutralize the toxic effects of toxin A and/or toxin B, showcasing her innovative approach to addressing serious health concerns.
Career Highlights
Throughout her career, Stefanie has worked with notable companies such as Valneva Austria GmbH and Valneva USA, Inc. Her experience in these organizations has allowed her to collaborate with other experts in the field and further her research on toxin neutralization.
Collaborations
Stefanie has collaborated with esteemed colleagues, including Larry R Ellingsworth and David Flyer. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Stefanie Kluepfel-Stahl is a remarkable inventor whose work in toxin neutralization has the potential to make a significant impact in the medical field. Her innovative patents and collaborations highlight her dedication to advancing biochemistry and improving health outcomes.